Neoadjuvante systemische therapie bij het primair operabel mammacarcinoom: meer voordelen dan alleen borstsparende behandeling

Translated title of the contribution: Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy

M E Straver, J C van Adrichem, E J Th Rutgers, S Rodenhuis, S.C. Linn, C E Loo, K G Gilhuijs, J Wesseling, H S A Oldenburg, N S Russell, N Antonini, M T F D Vrancken Peeters

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science